捐赠心脏中的肌肉心脏功能障碍. 一个可能的病因学
V J Owen1, P B Burton, M C Michel
1Cardiothoracic Surgery, National Heart and Lung Institute at Imperial College School of Medicine, London, UK. v.j.owen@ic.ac.uk
Circulation
|May 20, 1999
概括
抑制性G蛋白Gialpha活性增加有助于急性衰竭的供体心脏的收缩能力受损. 这与处理蛋白和β-受体密度的变化形成鲜明对比,而这些都不是常见的原因.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 移植科学 移植科学
背景情况:
- 未使用的供体心脏往往表现出心肌功能障碍,使其不适合移植.
- 这些心脏中急性心力衰竭的潜在机制仍然不清楚.
- 这项研究调查了潜在的原因,包括处理的蛋白质,β-adrenoceptor密度和抑制性G蛋白Gialpha.
研究的目的:
- 确定急性衰竭供体心脏收缩功能障碍的分子基础.
- 为了比较未使用的捐赠心脏的变化与末期失败和不失败的心脏的变化.
- 确定导致心脏功能受损的关键蛋白质标.
主要方法:
- 从未使用的供体心脏 (射出分数<30%),末期失败的心脏和非失败的心脏中分析心肌样本.
- 在体外测试中,对轨道细胞和分离的肌细胞中的内功能进行了评估.
- 量化特定的处理蛋白 (SERCA,NCX),β-腺素受体密度和Gialpha活性.
主要成果:
- 未使用的捐赠心脏显示收缩功能障碍与心脏衰竭相似.
- 肉质网膜-ATPase和-交换器丰度的变化在两组中都不常见.
- 在失败的心脏中,β-上腺体受体密度降低了,但在未使用的供体心脏中没有降低.
- 在未使用的捐赠者和失败的心脏中观察到抑制性G蛋白Gialpha活性增加.
结论:
- 升高的Gialpha活性是急性衰竭的供体心脏收缩能力受损的重要因素.
- 这一发现区分了该机制与处理蛋白或β-受体密度的变化.
- 向Gialpha可能为保护捐赠心脏中的心脏功能提供治疗潜力.
相关概念视频
Cell-mediated Immune Responses
Overview
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...


